Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway

Purpose: Functional impairment of endothelial progenitor cells (EPCs) is frequently observed in patients with diabetic vascular complications. Astragaloside IV (ASV) has a significant protective effect against vascular endothelial dysfunction. Thus, this study aimed to investigate the role of ASV on...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Weibin, Cai, Xinrui, Qian, Qiuhai, Zhuang, Qianzhu, Yang, Wenjun, Zhang, Xinying, Zhao, Lijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677131/
https://www.ncbi.nlm.nih.gov/pubmed/31440038
http://dx.doi.org/10.2147/DDDT.S207774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677131/
https://www.ncbi.nlm.nih.gov/pubmed/31440038
http://dx.doi.org/10.2147/DDDT.S207774

Ejemplares similares